The overall goal of this Program Project is to identify the mechanisms that alter normal growth control to bring about neoplastic transformation. Cell proliferation is normally regulated by coordinated mechanisms that stimulate or inhibit growth and modulate differentiation and development. The overall focus of this program is the investigation of the basic control mechanisms through which growth inhibitory proteins and inducers of differentiation modulate cell proliferation and development. Alterations in these controls may lead to cancer. The program is composed of 3 projects that involve the use of biochemical, cell and molecular technologies and transgenic mouse models. Project 2 will use transgenic mice to investigate the role of TGFBeta in the regulation of mammary development, and will test the hypothesis that loss of TGFBeta inhibition and over production of TGFalpha promote development of mammary carcinoma. The mechanism by which TGFbeta inhibits proliferation will also be studied. Project 3 will use molecular biological techniques to determine the function of the three c-Myc proteins in the regulation of growth and differentiation. The capacity of Myc proteins to enhance transcription will be examined, and transgenic mice used to determine effects of the Myc proteins on the induction and suppression of breast tumors. Project 4 will investigate the role of DVR-6 in the growth and differentiation of specific cells and tissues in the mouse embryo. Misexpression of DVR-6 in transgenic mice and generation of DVR-6 null mutants will be used as complementary approaches to elucidate the function of DVR-6 in development. Thy synthesis, secretion and post-transnational modification of DVR-6 by a variety of cells will also be studied. The 3 research projects will be supported by two cores. This program brings together six investigators in 3 projects that integrate the study of cell proliferation with differentiation and development. The proposed studies focus on cell and animal models to characterize the process that alter normal growth control and lead to cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA048799-06
Application #
2093073
Study Section
Special Emphasis Panel (SRC (J1))
Project Start
1989-08-02
Project End
1997-12-31
Budget Start
1995-03-01
Budget End
1995-12-31
Support Year
6
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Satterwhite, D J; White, R L; Aakre, M E et al. (2001) TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1. Pediatr Res 50:67-75
Engel, M E; McDonnell, M A; Law, B K et al. (1999) Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274:37413-20
Norgaard, P; Law, B; Joseph, H et al. (1999) Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis. Clin Cancer Res 5:35-42
Lutterbach, B; Hann, S R (1999) c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J Cell Biochem 72:483-91
Gorska, A E; Joseph, H; Derynck, R et al. (1998) Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 9:229-38
Alexandrow, M G; Moses, H L (1998) c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. J Cell Biochem 70:528-42
Zhao, G Q; Liaw, L; Hogan, B L (1998) Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis. Development 125:1103-12
Engel, M E; Datta, P K; Moses, H L (1998) RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation. J Biol Chem 273:9921-6
Datta, P K; Chytil, A; Gorska, A E et al. (1998) Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling. J Biol Chem 273:34671-4
Serra, R; Johnson, M; Filvaroff, E H et al. (1997) Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541-52

Showing the most recent 10 out of 62 publications